NCT05197205 Nasopharyngeal Bacterial Carriage and Antibiotic Resistance in Children With Sickle Cell Disease in Ile-De-France Status UNKNOWN Phase NA
NCT05170412 Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease Status RECRUITING Phase N/A
NCT05169580 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir Status COMPLETED Phase PHASE1
NCT05153967 Cooperative Assessment of Late Effects for SCD Curative Therapies Status RECRUITING Phase N/A
NCT05153044 Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France Status UNKNOWN Phase NA
NCT05143021 Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05099874 Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease Status RECRUITING Phase NA
NCT05098028 Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT05084521 Interest of Famotidine in Children With Sickle Cell Disease Status COMPLETED Phase PHASE2/PHASE3
NCT05081349 Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia Status COMPLETED Phase PHASE4
NCT05075824 A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE2
NCT05053932 Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia Status COMPLETED Phase N/A
NCT05045820 Integrative Medicine in Pain Management in Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT05036512 A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants Status COMPLETED Phase PHASE1
NCT05033314 THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) Status TERMINATED Phase PHASE3
NCT05031780 A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05020873 Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and India Status TERMINATED Phase N/A
NCT05012631 Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT04987489 A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease Status COMPLETED Phase PHASE2